James E Crowe1. 1. Departments of Pediatrics and Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vanderbilt.edu
Abstract
BACKGROUND: Human metapneumovirus (hMPV) is a newly identified paramyxovirus that appears to be one of the most significant and common viral infections in humans. The virus, first isolated in 2001, is a clear cause of lower respiratory tract disease in both the very young and the frail elderly. The virus causes acute wheezing in children or, less commonly, croup or pneumonia. METHODS/ RESULTS: Molecular epidemiology studies have shown that field strains exhibit sufficient sequence diversity to designate 2 subgroups of circulating viruses. Small animal and nonhuman primate models of infection have been described, which will allow studies of pathogenesis and immunity. Recombinant viruses have already been generated by several groups using reverse genetics, which facilitates the study of the biology of the virus and the generation of live attenuated vaccine candidates. CONCLUSIONS: Ongoing research promises to elucidate the molecular basis for pathogenesis and immunity of human metapneumovirus infections and to pave the way for rapid vaccine development.
BACKGROUND:Human metapneumovirus (hMPV) is a newly identified paramyxovirus that appears to be one of the most significant and common viral infections in humans. The virus, first isolated in 2001, is a clear cause of lower respiratory tract disease in both the very young and the frail elderly. The virus causes acute wheezing in children or, less commonly, croup or pneumonia. METHODS/ RESULTS: Molecular epidemiology studies have shown that field strains exhibit sufficient sequence diversity to designate 2 subgroups of circulating viruses. Small animal and nonhuman primate models of infection have been described, which will allow studies of pathogenesis and immunity. Recombinant viruses have already been generated by several groups using reverse genetics, which facilitates the study of the biology of the virus and the generation of live attenuated vaccine candidates. CONCLUSIONS: Ongoing research promises to elucidate the molecular basis for pathogenesis and immunity of humanmetapneumovirus infections and to pave the way for rapid vaccine development.
Authors: Guillermina A Melendi; Fidel Zavala; Ursula J Buchholz; Guy Boivin; Peter L Collins; Steven R Kleeberger; Fernando P Polack Journal: J Virol Date: 2007-08-01 Impact factor: 5.103
Authors: Nancy D Ulbrandt; Hong Ji; Nita K Patel; Jeffrey M Riggs; Yambasu A Brewah; Shannon Ready; Nanci E Donacki; Karyn Folliot; Arnita S Barnes; Kannaki Senthil; Susan Wilson; Mingzhong Chen; Lori Clarke; Mia MacPhail; Jia Li; Robert M Woods; Kathy Coelingh; Jennifer L Reed; Michael P McCarthy; David S Pfarr; Albert D M E Osterhaus; Ron A M Fouchier; Peter A Kiener; JoAnn A Suzich Journal: J Virol Date: 2006-08 Impact factor: 5.103
Authors: José Ordás; José Antonio Boga; Marta Alvarez-Argüelles; Laura Villa; Cristina Rodríguez-Dehli; María de Oña; Julián Rodríguez; Santiago Melón Journal: J Clin Microbiol Date: 2006-08 Impact factor: 5.948
Authors: W Abdullah Brooks; Dean Erdman; Pauline Terebuh; Alexander Klimov; Doli Goswami; Amina Tahia Sharmeen; Tasnim Azim; Stephen Luby; Carolyn Bridges; Robert Breiman Journal: Emerg Infect Dis Date: 2007-10 Impact factor: 6.883